Nyumbani › Uzito Kupita Kiasi › Arizona
Majaribio ya kliniki ya Uzito Kupita Kiasi katika jimbo la Arizona
Masomo 29 ya Uzito Kupita Kiasi yanatafuta washiriki katika vituo vya jimbo la Arizona.
Miji katika jimbo la Arizona
- TucsonUtafiti 15
- PhoenixUtafiti 15
- ScottsdaleUtafiti 5
- MesaUtafiti 4
- PeoriaUtafiti 4
- ChandlerUtafiti 4
- GilbertUtafiti 3
Maandishi rasmi ya utafiti (Kiingereza)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Headlands Research - Scottsdale /ID# 282571, Scottsdale
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- AMR Clinical, Tempe
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Care Access - 801 South Power Road, Mesa, Mesa
- Absolute Clinical Research, Phoenix
- Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07794579A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Arizona, Tucson
InaajiriHatua 3
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- RIO Clinical Trials - Phoenix, Phoenix
- Headlands Research - Scottsdale, Scottsdale
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
InaajiriHatua 3
Umri 45 hadi 99 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Headlands Research - Scottsdale, Scottsdale
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Care Access - 801 South Power Road, Mesa, Mesa
- Elite Pain and Spine Institute - South Crimson Road, Mesa
- Elite Clinical Studies, LLC, Phoenix
- na zaidi ya 1
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
- Headlands Research - Scottsdale, Scottsdale
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589608A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Phoenix
- AURORA-1 Clinical Site, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Peoria
- AURORA-2 Clinical Site, Phoenix
- AURORA-2 Clinical Site, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Arizona Clinical Trials, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Helios Clinical Research - Phoenix, Phoenix
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Arizona Clinical Trials, Tucson
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Chandler
- ACCOMPLISH-2 Research Site, Phoenix
- ACCOMPLISH-2 Research Site, Sun City West
- na zaidi ya 1
InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Dignity Health, Mercy Gilbert, Gilbert
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07571109A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
- Headlands Research - Scottsdale, Scottsdale
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06143956A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
- Synexus Clinical Research US, Inc., Phoenix
- Pima Heart, Tucson
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Medical Dermatology Specialists, Phoenix
InaajiriHatua 4
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Phoenix
- Kailera Clinical Site, Sun City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Sun City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Gilbert Center for Family Medicine, Gilbert
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07684144Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Arizona Clinical Trials, Chandler
- Epic Medical Research - Sun City, Sun City
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Mesa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT07784725Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
- Exponent Phoenix, Phoenix
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT07776678Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Phoenix
- ACCOMPLISH-1 Research Site, Sun City West
- ACCOMPLISH-1 Research Site, Tucson
InaajiriHatua 3
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07654361Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- The University of Arizona College of Medicine- Phoenix, Phoenix
InaajiriHatua 3
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 14 Nov 2025 · NCT06499857Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.